Menu
Back to Journals » Risk Management and Healthcare Policy » Volume 16
Original Research
Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,936 | Dovepress* | 1,808+ | 63 | 1,871 | |
| PubMed Central* | 128 | 41 | 169 | ||
| Totals | 1,936 | 104 | 2,040 | ||
| *Since 15 November 2023 | |||||
View citations on PubMed Central and Google Scholar